These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32378649)

  • 1. Effects of the combined administration of risedronate and menatetrenone on bone loss induced by tacrolimus in rats.
    Kanda J; Furukawa M; Izumo N; Shimakura T; Yamamoto N; Takahashi HE; Wakabayashi H
    Drug Discov Ther; 2020; 14(2):77-83. PubMed ID: 32378649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives) in osteopenia induced by phenytoin in growing rats.
    Onodera K; Takahashi A; Wakabayashi H; Kamei J; Sakurada S
    Nutrition; 2003 May; 19(5):446-50. PubMed ID: 12714099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats.
    Onodera K; Takahashi A; Sakurada S; Okano Y
    Life Sci; 2002 Feb; 70(13):1533-42. PubMed ID: 11895104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Nutr Rev; 2006 Dec; 64(12):509-17. PubMed ID: 17274493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trial.
    Sato Y; Honda Y; Umeno K; Hayashida N; Iwamoto J; Takeda T; Matsumoto H
    Kurume Med J; 2011; 57(4):117-24. PubMed ID: 21778673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
    Yonemura K; Kimura M; Miyaji T; Hishida A
    Calcif Tissue Int; 2000 Feb; 66(2):123-8. PubMed ID: 10652960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry study.
    Iwamoto J; Matsumoto H; Tadeda T; Sato Y; Yeh JK
    Yonsei Med J; 2009 Apr; 50(2):189-94. PubMed ID: 19430549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.
    Matsumoto Y; Mikuni-Takagaki Y; Kozai Y; Miyagawa K; Naruse K; Wakao H; Kawamata R; Kashima I; Sakurai T
    Osteoporos Int; 2009 Nov; 20(11):1863-72. PubMed ID: 19280272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis.
    Shiraishi A; Higashi S; Masaki T; Saito M; Ito M; Ikeda S; Nakamura T
    Calcif Tissue Int; 2002 Jul; 71(1):69-79. PubMed ID: 12073154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
    Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
    Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of menatetrenone on bone loss induced by ovariectomy in rats.
    Akiyama Y; Hara K; Ohkawa I; Tajima T
    Jpn J Pharmacol; 1993 Jun; 62(2):145-53. PubMed ID: 8371513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.
    Hara K; Kobayashi M; Akiyama Y
    Bone; 2002 Nov; 31(5):575-81. PubMed ID: 12477571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the calcineurin inhibitors cyclosporine and tacrolimus on bone metabolism in rats.
    Kanda J; Izumo N; Furukawa M; Shimakura T; Yamamoto N; E Takahashi H; Asakura T; Wakabayashi H
    Biomed Res; 2018; 39(3):131-139. PubMed ID: 29899188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
    Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.